MedPath

GLEOLAN

GLEOLAN

Approved
DIN Number

02504928

Drug Class

Human

Market Date

Feb 22, 2021

Company
HC

medexus pharmaceuticals inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02504928
AIG Number0143983002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XD04 AMINOLEVULINIC ACID
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationOral
AHFS Classification36:68.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

AMINOLEVULINIC ACID HYDROCHLORIDEActive
Strength: 1.5 G / VIAL
Monograph: AMINOLEVULINIC ACID HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.